Veracyte
VCYT
$20.19
Share price
0.30%
Change (1 day)
-3.67%
Change (1 year)
Categories
Veracyte (VCYT) - Net assets
Net assets on the balance sheet as of December 2023 : $1.04 B
According to Veracyte's latest financial reports the company has $1.04 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Veracyte - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $1.04 B | -2.89% |
| 2022-12-31 | $1.07 B | -1.94% |
| 2021-12-31 | $1.09 B | 160.31% |
| 2020-12-31 | $0.42 B | 75.91% |
| 2019-12-31 | $0.23 B | 200.24% |
| 2018-12-31 | $79.75 M | 114.25% |
| 2017-12-31 | $37.22 M | -37.52% |
| 2016-12-31 | $59.58 M | 16.25% |
| 2015-12-31 | $51.25 M | 23.87% |
| 2014-12-31 | $41.37 M | -26.7% |
| 2013-12-31 | $56.44 M | 1051.66% |
| 2012-12-31 | $4.9 M | -42.54% |
| 2011-12-31 | $8.53 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | $3.14 B | 201.25% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.78 B | -24.99% | 🇺🇸 USA |
 Biocept
BIOC | $0.29 M | -99.97% | 🇺🇸 USA |